Office of the Director, Office of Science Policy; Meeting, 17847-17848 [2017-07511]

Download as PDF Federal Register / Vol. 82, No. 70 / Thursday, April 13, 2017 / Notices Dated: April 10, 2017. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–07508 Filed 4–12–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings asabaliauskas on DSK3SPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Loan Repayment Application Review. Date: April 27, 2017. Time: 2:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: John F. Connaughton, Ph.D., Chief, Scientific Review Branch, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7007, 6707 Democracy Boulevard, Bethesda, MD 20892– 5452, (301) 594–7797, connaughtonj@ extra.niddk.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Time-Sensitive Obesity Policy and Program Evaluation. Date: April 28, 2017. Time: 2:00 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Michele L. Barnard, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, VerDate Sep<11>2014 17:51 Apr 12, 2017 Jkt 241001 Room 7353, 6707 Democracy Boulevard, Bethesda, MD 20892–2542, (301) 594–8898, barnardm@extra.niddk.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: April 10, 2017. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–07510 Filed 4–12–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of a meeting of the NIH Clinical Center Research Hospital Board. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The portion of the meeting devoted to the identification and evaluation of specific candidates for consideration for leadership positions in the Clinical Center will be closed to the public in accordance with the provisions set forth in section 552b(c)(9)(B) and 552b(c)(6), Title 5 U.S.C., as amended. Premature disclosure of potential candidates and their qualifications, as well as the discussions by the committee, could significantly frustrate NIH’s ability to recruit these individuals and the consideration of personnel qualifications, performance, and the competence of individuals as candidates would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: NIH Clinical Center Research Hospital Board. Date: April 28, 2017. Open: 8:30 a.m. to 3:20 p.m. Agenda: Clinical Center Tour (8:30–9:45) Welcome and Board Chair’s Overview; NIH Director’s Remarks, NIH CC CEO: First 100 PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 17847 Days; CCRHB-Clinical Center Governing Board Joint Session; Delayed Reporting Root Cause Analysis; Clinical Trials Support Realignment. Place: Conference Room 6C6 (except for Clinical Center Tour), Building 31, National Institutes of Health, Bethesda, MD 20892. Closed: 3:20 p.m. to 5:00 p.m. Agenda: Identification of Candidates for Leadership Roles. Place: Conference Room 6C6, Building 31, National Institutes of Health, Bethesda, MD 20892. Contact Person: Gretchen Wood, Staff Assistant, National Institutes of Health, Office of the Director, One Center Drive, Building 1, Room 126, Bethesda, MD 20892, 301–496–4272, woodgs@od.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Dated: April 7, 2017. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2017–07427 Filed 4–12–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, Office of Science Policy; Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the meeting of the National Science Advisory Board for Biosecurity (NSABB). Name of Committee: National Science Advisory Board for Biosecurity. Date: May 11, 2017. Time: 2:00 p.m.–4:30 p.m. Eastern. Agenda: Presentations and discussions regarding: (1) The Blue Ribbon Panel draft report on the 2014 variola virus incident on the NIH Bethesda campus; (2) stakeholder engagement on implementation of the U.S. Government Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern (DURC); and (3) other business of the Board. E:\FR\FM\13APN1.SGM 13APN1 17848 Federal Register / Vol. 82, No. 70 / Thursday, April 13, 2017 / Notices asabaliauskas on DSK3SPTVN1PROD with NOTICES Place: Telephone conference call only (no in-person meeting), Public Dial-in (US Toll Free): 1–866–939–3921, Confirmation Number: 44675525. Contact Person: Jessica Tucker, Ph.D., Executive Director, NSABB, NIH Office of Science Policy, 6705 Rockledge Drive, Suite 750, Bethesda, Maryland 20892, (301) 451– 4431, jessica.tucker@nih.gov. Under authority 42 U.S.C. 217a, section 222 of the Public Health Service Act, as amended, the Department of Health and Human Services established the National Science Advisory Board for Biosecurity (NSABB) to provide advice regarding federal oversight of dual use research—defined as legitimate biological research that generates information and technologies that could be misused to pose a biological threat to public health and/or national security. The toll-free teleconference line will be open to the public at 1:30 p.m. to allow time for operator-assisted checkin. Members of the public planning to participate in the teleconference may also pre-register online via the link provided below or by calling Palladian Partners, Inc. (Contact: Carly Sullivan at 301–318–0841). Pre-registration will close at 12:00 p.m. Eastern on May 8, 2017. After that time, attendees may register their information with the teleconference operator upon dialing into the meeting. Individuals who plan to participate and need special assistance should submit a request to the contact person listed on this notice by May 3, 2017. Meeting materials: The meeting agenda, background material, and online pre-registration will be available at: https://palladianpartners.cvent.com/ nsabbmay2017. Please check this Web site for updates. Public Comments: Time will be allotted on the agenda for the delivery of oral public comments. Members of the public interested in delivering prepared comments relevant to the mission of the NSABB should indicate so upon registration. Sign-up for delivering prepared oral comments will be limited to one per person or organization representative per open comment period. Individual comments will be time-limited to facilitate broad participation from multiple speakers. In addition, interested persons may file written comments at any time with the Board via an email sent to nsabb@ od.nih.gov or by regular mail sent to the Contact Person listed on this notice. Written statements should include the name, contact information, and when applicable, the professional affiliation of the interested person. Written comments received by 12:00 p.m. Eastern on May 8, 2017 will be relayed VerDate Sep<11>2014 17:51 Apr 12, 2017 Jkt 241001 to the NSABB prior to the teleconference meeting. Any written comments received after this deadline will be provided to the Board either before or after the meeting, depending on the volume of comments received and the time required to process them in accordance with privacy regulations and other applicable federal policies. Dated: April 10, 2017. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–07511 Filed 4–12–17; 8:45 am] BILLING CODE 4140–01–P Disaster Grants—Public Assistance (Presidentially Declared Disasters); 97.039, Hazard Mitigation Grant. Robert J. Fenton, Acting Administrator, Federal Emergency Management Agency. [FR Doc. 2017–07430 Filed 4–12–17; 8:45 am] BILLING CODE 9111–23–P DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency [Internal Agency Docket No. FEMA–4305– DR; Docket ID FEMA–2017–0001] DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency [Internal Agency Docket No. FEMA–4304– DR; Docket ID FEMA–2017–0001] Kansas; Amendment No. 1 to Notice of a Major Disaster Declaration Federal Emergency Management Agency, DHS. ACTION: Notice. AGENCY: This notice amends the notice of a major disaster declaration for the State of Kansas (FEMA–4304–DR), dated February 24, 2017, and related determinations. DATES: Effective March 23, 2017. FOR FURTHER INFORMATION CONTACT: Dean Webster, Office of Response and Recovery, Federal Emergency Management Agency, 500 C Street SW., Washington, DC 20472, (202) 646–2833. SUPPLEMENTARY INFORMATION: The notice of a major disaster declaration for the State of Kansas is hereby amended to include the following areas among those areas determined to have been adversely affected by the event declared a major disaster by the President in his declaration of February 24, 2017. SUMMARY: Rice and Russell Counties for Public Assistance. The following Catalog of Federal Domestic Assistance Numbers (CFDA) are to be used for reporting and drawing funds: 97.030, Community Disaster Loans; 97.031, Cora Brown Fund; 97.032, Crisis Counseling; 97.033, Disaster Legal Services; 97.034, Disaster Unemployment Assistance (DUA); 97.046, Fire Management Assistance Grant; 97.048, Disaster Housing Assistance to Individuals and Households In Presidentially Declared Disaster Areas; 97.049, Presidentially Declared Disaster Assistance— Disaster Housing Operations for Individuals and Households; 97.050 Presidentially Declared Disaster Assistance to Individuals and Households—Other Needs; 97.036, PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 California; Major Disaster and Related Determinations Federal Emergency Management Agency, DHS. ACTION: Notice. AGENCY: This is a notice of the Presidential declaration of a major disaster for the State of California (FEMA–4305–DR), dated March 16, 2017, and related determinations. DATES: Effective March 16, 2017. FOR FURTHER INFORMATION CONTACT: Dean Webster, Office of Response and Recovery, Federal Emergency Management Agency, 500 C Street SW., Washington, DC 20472, (202) 646–2833. SUPPLEMENTARY INFORMATION: Notice is hereby given that, in a letter dated March 16, 2017, the President issued a major disaster declaration under the authority of the Robert T. Stafford Disaster Relief and Emergency Assistance Act, 42 U.S.C. 5121 et seq. (the ‘‘Stafford Act’’), as follows: SUMMARY: I have determined that the damage in certain areas of the State of California resulting from severe winter storms, flooding, and mudslides during the period of January 18–23, 2017, is of sufficient severity and magnitude to warrant a major disaster declaration under the Robert T. Stafford Disaster Relief and Emergency Assistance Act, 42 U.S.C. 5121 et seq. (the ‘‘Stafford Act’’). Therefore, I declare that such a major disaster exists in the State of California. In order to provide Federal assistance, you are hereby authorized to allocate from funds available for these purposes such amounts as you find necessary for Federal disaster assistance and administrative expenses. You are authorized to provide Public Assistance in the designated areas and Hazard Mitigation throughout the State. Consistent with the requirement that Federal assistance be supplemental, any Federal funds provided under the Stafford Act for Hazard Mitigation will be limited to 75 percent of the total eligible costs. Federal funds provided under the Stafford Act for Public Assistance also will be limited to 75 E:\FR\FM\13APN1.SGM 13APN1

Agencies

[Federal Register Volume 82, Number 70 (Thursday, April 13, 2017)]
[Notices]
[Pages 17847-17848]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-07511]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, Office of Science Policy; Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the meeting of the 
National Science Advisory Board for Biosecurity (NSABB).

    Name of Committee: National Science Advisory Board for 
Biosecurity.
    Date: May 11, 2017.
    Time: 2:00 p.m.-4:30 p.m. Eastern.
    Agenda: Presentations and discussions regarding: (1) The Blue 
Ribbon Panel draft report on the 2014 variola virus incident on the 
NIH Bethesda campus; (2) stakeholder engagement on implementation of 
the U.S. Government Policy for Institutional Oversight of Life 
Sciences Dual Use Research of Concern (DURC); and (3) other business 
of the Board.

[[Page 17848]]

    Place: Telephone conference call only (no in-person meeting), 
Public Dial-in (US Toll Free): 1-866-939-3921, Confirmation Number: 
44675525.
    Contact Person: Jessica Tucker, Ph.D., Executive Director, 
NSABB, NIH Office of Science Policy, 6705 Rockledge Drive, Suite 
750, Bethesda, Maryland 20892, (301) 451-4431, 
jessica.tucker@nih.gov.

    Under authority 42 U.S.C. 217a, section 222 of the Public Health 
Service Act, as amended, the Department of Health and Human Services 
established the National Science Advisory Board for Biosecurity (NSABB) 
to provide advice regarding federal oversight of dual use research--
defined as legitimate biological research that generates information 
and technologies that could be misused to pose a biological threat to 
public health and/or national security.
    The toll-free teleconference line will be open to the public at 
1:30 p.m. to allow time for operator-assisted check-in. Members of the 
public planning to participate in the teleconference may also pre-
register online via the link provided below or by calling Palladian 
Partners, Inc. (Contact: Carly Sullivan at 301-318-0841). Pre-
registration will close at 12:00 p.m. Eastern on May 8, 2017. After 
that time, attendees may register their information with the 
teleconference operator upon dialing into the meeting. Individuals who 
plan to participate and need special assistance should submit a request 
to the contact person listed on this notice by May 3, 2017.
    Meeting materials: The meeting agenda, background material, and 
online pre-registration will be available at: https://palladianpartners.cvent.com/nsabbmay2017. Please check this Web site 
for updates.
    Public Comments: Time will be allotted on the agenda for the 
delivery of oral public comments. Members of the public interested in 
delivering prepared comments relevant to the mission of the NSABB 
should indicate so upon registration. Sign-up for delivering prepared 
oral comments will be limited to one per person or organization 
representative per open comment period. Individual comments will be 
time-limited to facilitate broad participation from multiple speakers.
    In addition, interested persons may file written comments at any 
time with the Board via an email sent to nsabb@od.nih.gov or by regular 
mail sent to the Contact Person listed on this notice. Written 
statements should include the name, contact information, and when 
applicable, the professional affiliation of the interested person. 
Written comments received by 12:00 p.m. Eastern on May 8, 2017 will be 
relayed to the NSABB prior to the teleconference meeting. Any written 
comments received after this deadline will be provided to the Board 
either before or after the meeting, depending on the volume of comments 
received and the time required to process them in accordance with 
privacy regulations and other applicable federal policies.

    Dated: April 10, 2017.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-07511 Filed 4-12-17; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.